Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Castilletti

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19Stefania Capone, Angelo Raggioli, Michela Gentile, et al.
Biomedicines|January 22, 2021
Immunogenicity of Viral Vaccines in the Italian MilitaryClaudia Ferlito, Roberto Biselli, Vincenzo Visco, et al.
Frontiers in Immunology|October 1, 2021
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis PatientsAndrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, et al.
Science Translational Medicine|December 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153Ida Paciello, Emily J Rundlet, Ling Zhou, et al.
Frontiers in Immunology|June 12, 2023
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boostersEva Piano Mortari, Federica Pulvirenti, Valentina Marcellini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2022
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte CountAndrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Biomedicines|January 21, 2022
Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after ImmunizationClaudia Ferlito, Vincenzo Visco, Roberto Biselli, et al.
Neurology|November 23, 2021
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying TherapiesCarla Tortorella, Alessandra Aiello, Claudio Gasperini, et al.
International Immunopharmacology|September 25, 2025
Genetic variability of respiratory syncytial virus and its impact on monoclonal antibody binding sites: a national cross-sectional study during the 2023-2024 seasonAntonio Piralla, Greta Romano, Carla Acciarri, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Epidemiological and genomic features of chikungunya virus disease in travellers returning from Cuba, September 2025 to January 2026: a GeoSentinel analysisMarta Díaz-Menéndez, Concetta Castilletti, Kevin O'Laughlin, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19Stefania Capone, Angelo Raggioli, Michela Gentile, et al.
Biomedicines|January 22, 2021
Immunogenicity of Viral Vaccines in the Italian MilitaryClaudia Ferlito, Roberto Biselli, Vincenzo Visco, et al.
Frontiers in Immunology|October 1, 2021
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis PatientsAndrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, et al.
Science Translational Medicine|December 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153Ida Paciello, Emily J Rundlet, Ling Zhou, et al.
Frontiers in Immunology|June 12, 2023
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boostersEva Piano Mortari, Federica Pulvirenti, Valentina Marcellini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2022
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte CountAndrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Biomedicines|January 21, 2022
Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after ImmunizationClaudia Ferlito, Vincenzo Visco, Roberto Biselli, et al.
Neurology|November 23, 2021
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying TherapiesCarla Tortorella, Alessandra Aiello, Claudio Gasperini, et al.
International Immunopharmacology|September 25, 2025
Genetic variability of respiratory syncytial virus and its impact on monoclonal antibody binding sites: a national cross-sectional study during the 2023-2024 seasonAntonio Piralla, Greta Romano, Carla Acciarri, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Epidemiological and genomic features of chikungunya virus disease in travellers returning from Cuba, September 2025 to January 2026: a GeoSentinel analysisMarta Díaz-Menéndez, Concetta Castilletti, Kevin O'Laughlin, et al.
Pageof 19